Luca Richeldi

Summary

Affiliation: University of Modena and Reggio Emilia
Country: Italy

Publications

  1. doi request reprint Performance of tests for latent tuberculosis in different groups of immunocompromised patients
    Luca Richeldi
    Section of Respiratory Diseases, Department of Oncology, Hematology and Respiratory Diseases, University of Modena and Reggio Emilia, Italy
    Chest 136:198-204. 2009
  2. pmc Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials
    Harold R Collard
    University of California San Francisco, San Francisco, CA, USA
    Respir Res 14:73. 2013
  3. pmc Recommendations on treatment for IPF
    Jurgen Behr
    Department of Internal Medicine V, University of Munich, Comprehensive Pneumology Center, Marchioninistr, 15, 81377 Munich, Germany
    Respir Res 14:S6. 2013
  4. doi request reprint Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis
    Luca Richeldi
    Centre for Rare Lung Diseases, University of Modena and Reggio Emilia, Modena, Italy
    Eur Respir J 42:230-8. 2013
  5. pmc Clinical trials of investigational agents for IPF: a review of a Cochrane report
    Luca Richeldi
    Centre for Rare Lung Disease, University of Modena and Reggio Emilia, Modena, Italy
    Respir Res 14:S4. 2013
  6. pmc Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis
    Paola Contini
    Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Modena, Italy
    Multidiscip Respir Med 6:313-7. 2011
  7. doi request reprint Assessing the treatment effect from multiple trials in idiopathic pulmonary fibrosis
    Luca Richeldi
    Centre for Rare Lung Disease, Policlinico University Hospital, Modena, Italy
    Eur Respir Rev 21:147-51. 2012
  8. doi request reprint Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis
    Luca Richeldi
    Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Policlinico Hospital, Via del Pozzo 71, 41100 Modena, Italy
    Thorax 67:407-11. 2012
  9. doi request reprint Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis
    Luca Richeldi
    Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
    N Engl J Med 365:1079-87. 2011
  10. ncbi request reprint Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay
    Luca Richeldi
    Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Policlinico Hospital, Via del Pozzo 71, 41100 Modena, Italy
    Expert Rev Respir Med 2:253-60. 2008

Collaborators

Detail Information

Publications31

  1. doi request reprint Performance of tests for latent tuberculosis in different groups of immunocompromised patients
    Luca Richeldi
    Section of Respiratory Diseases, Department of Oncology, Hematology and Respiratory Diseases, University of Modena and Reggio Emilia, Italy
    Chest 136:198-204. 2009
    ....
  2. pmc Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials
    Harold R Collard
    University of California San Francisco, San Francisco, CA, USA
    Respir Res 14:73. 2013
    ..Acute exacerbation of idiopathic pulmonary fibrosis has become an important outcome measure in clinical trials. This study aimed to explore the concept of suspected acute exacerbation as an outcome measure...
  3. pmc Recommendations on treatment for IPF
    Jurgen Behr
    Department of Internal Medicine V, University of Munich, Comprehensive Pneumology Center, Marchioninistr, 15, 81377 Munich, Germany
    Respir Res 14:S6. 2013
    ....
  4. doi request reprint Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis
    Luca Richeldi
    Centre for Rare Lung Diseases, University of Modena and Reggio Emilia, Modena, Italy
    Eur Respir J 42:230-8. 2013
    ....
  5. pmc Clinical trials of investigational agents for IPF: a review of a Cochrane report
    Luca Richeldi
    Centre for Rare Lung Disease, University of Modena and Reggio Emilia, Modena, Italy
    Respir Res 14:S4. 2013
    ..In addition, there are numerous ongoing trials investigating potential therapeutic agents which provides hope for IPF patients and their doctors...
  6. pmc Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis
    Paola Contini
    Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Modena, Italy
    Multidiscip Respir Med 6:313-7. 2011
    ....
  7. doi request reprint Assessing the treatment effect from multiple trials in idiopathic pulmonary fibrosis
    Luca Richeldi
    Centre for Rare Lung Disease, Policlinico University Hospital, Modena, Italy
    Eur Respir Rev 21:147-51. 2012
    ..The findings of this systematic review, although not presenting new original data, together with an acceptable safety profile, suggest that pirfenidone may have a role in IPF treatment...
  8. doi request reprint Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis
    Luca Richeldi
    Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Policlinico Hospital, Via del Pozzo 71, 41100 Modena, Italy
    Thorax 67:407-11. 2012
    ..It is unknown if the method of calculating decline in FVC (relative vs. absolute change) impacts its frequency or its ability to predict mortality...
  9. doi request reprint Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis
    Luca Richeldi
    Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
    N Engl J Med 365:1079-87. 2011
    ....
  10. ncbi request reprint Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay
    Luca Richeldi
    Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Policlinico Hospital, Via del Pozzo 71, 41100 Modena, Italy
    Expert Rev Respir Med 2:253-60. 2008
    ....
  11. ncbi request reprint [Role of in vitro tests in the diagnosis of latent tubercular infections]
    Luca Richeldi
    Dipartimento di Oncologia, Ematologia e Patologie dell Apparato Respiratorio, Universita di Modena e Reggio Emilia, Italy
    G Ital Med Lav Ergon 32:269-72. 2010
    ..It's therefore desirable that new documents will be produced soon to guide the use of these new tests in clinical routine...
  12. ncbi request reprint Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents
    Barbara Maria Bergamini
    University of Modena and Reggio Emilia, Department of Respiratory Diseases, Policlinico Hospital of Modena, Via del Pozzo 71, 41100 Modena, Italy
    Pediatrics 123:e419-24. 2009
    ..TB (Oxford Immunotec, Abingdon, United Kingdom) show promise of greater accuracy, but they may also be affected by impaired cellular immunity, resulting in indeterminate results (ie, insufficient response in positive-control wells)...
  13. ncbi request reprint T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection
    Luca Richeldi
    Department of Respiratory Disease, University of Modena and Reggio Emilia, Modena, Italy
    Pediatrics 119:e1-5. 2007
    ..Our findings demonstrate that this blood test detected latent infection with dormant, yet viable, bacilli and illustrate how enzyme-linked immunospot could improve diagnosis of childhood tuberculosis infection...
  14. ncbi request reprint Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study
    Giovanni Ferrara
    Section of Respiratory Disease, Department of Oncology, Haematology, and Respiratory Disease, University of Modena and Reggio Emilia, Via del Pozzo, 71 41100 Modena, Italy
    Lancet 367:1328-34. 2006
    ..TB and QuantiFERON-TB Gold--have been separately compared with the tuberculin skin test. Our aim was to compare the efficacy of all three tests in the same population sample...
  15. doi request reprint Sarcoidosis: challenging diagnostic aspects of an old disease
    Paolo Spagnolo
    Section of Respiratory Diseases, Department of Oncology, Hematology, and Respiratory Diseases, University of Modena and Reggio Emilia, Modena, Italy
    Am J Med 125:118-25. 2012
    ..In conclusion, we strongly advise that physicians be ready to reconsider the diagnosis of sarcoidosis in the presence of atypical manifestations or persistent/progressive disease despite conventional therapy...
  16. ncbi request reprint Early diagnosis of subclinical multidrug-resistant tuberculosis
    Luca Richeldi
    University of Modena and Reggio Emilia and Azienda Ospedaliera Policlinico di Modena, Modena, Italy
    Ann Intern Med 140:709-13. 2004
    ..Rapid blood tests for Mycobacterium tuberculosis infection are a new alternative to the tuberculin skin test, but whether they improve clinical outcomes is unknown...
  17. doi request reprint Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature
    Michele Colaci
    Rheumatology Unit, University of Modena and Reggio Emilia, Modena, Italy
    Autoimmun Rev 12:374-9. 2013
    ..Our study confirmed the higher frequency of lung cancer among SSc patients compared to general population, particularly within patients' subset with serum anti-Scl70 antibodies and lung involvement...
  18. doi request reprint Management of idiopathic pulmonary fibrosis
    Stefania Cerri
    Center for Rare Lung Diseases, Department of Oncology, Hematology and Respiratory Diseases, University Hospital Policlinico of Modena, Modena, Italy
    Clin Chest Med 33:85-94. 2012
    ..Randomized controlled trials represent a valid choice for patients with IPF, and their completion is important in improving both survival and quality of life...
  19. ncbi request reprint Steroid and/or other immunosuppressive therapies in idiopathic interstitial pneumonias: have they still a role?
    Fabrizio Luppi
    Clinic of Respiratory Disease, Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena, Italy
    Sarcoidosis Vasc Diffuse Lung Dis 22:S74-84. 2005
    ..The aim of this review is to describe the level of evidence available on the efficacy of corticosteroids and immunosuppressive, antifibrotic, or immunomodulatory therapies in the treatment of different IIPs...
  20. doi request reprint Pirfenidone in idiopathic pulmonary fibrosis: the CAPACITY program
    Luca Richeldi
    University of Modena and Reggio Emilia, Modena, Italy
    Expert Rev Respir Med 5:473-81. 2011
    ..It is likely that pirfenidone will be utilised in many countries as first-line therapy and will also be included in studies of combination therapy for this attritional disease...
  21. pmc Genetic testing in diffuse parenchymal lung disease
    Paolo Spagnolo
    Department of Oncology, Center for Rare Lung Disease, Hematology, and Respiratory Diseases, University of Modena and Reggio Emilia, Via del Pozzo 71, Modena, 41124, Italy
    Orphanet J Rare Dis 7:79. 2012
    ..Finally, we discuss practical issues and implications for both patients and physicians of recent advances in the genetics of sarcoidosis and IPF...
  22. ncbi request reprint Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection
    Giovanni Ferrara
    Section of Respiratory Disease, Department of Oncology, Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Modena, Italy
    Am J Respir Crit Care Med 172:631-5. 2005
    ..The QuantiFERON-TB Gold (QFT-Gold) has been used in selected populations and shows higher specificity than the tuberculin skin test (TST)...
  23. doi request reprint The big clinical trials in idiopathic pulmonary fibrosis
    Fabrizio Luppi
    Center for Rare Lung Diseases, University Hospital of Modena, Modena, Italy
    Curr Opin Pulm Med 18:428-32. 2012
    ..Some of the most relevant trials have been published only recently...
  24. ncbi request reprint An update on the diagnosis of tuberculosis infection
    Luca Richeldi
    Department of Oncology, Hematology, and Respiratory Disease, University of Modena and Reggio Emilia, 41100 Modena, Italy
    Am J Respir Crit Care Med 174:736-42. 2006
    ....
  25. doi request reprint Eosinophilic globules in bronchoalveolar lavage fluid of patients with systemic sclerosis-related interstitial lung disease: a diagnostically useful, previously unreported finding in a retrospective and prospective study, including differential diagnosis
    Giulio Rossi
    Section of Pathologic Anatomy, Azienda Ospedaliero Universitaria Policlinico di Modena, Modena, Italy
    Am J Clin Pathol 130:927-33. 2008
    ..0001). Differential diagnosis with other types of acellular globular materials observed in BAL samples is also discussed...
  26. doi request reprint Environmental triggers and susceptibility factors in idiopathic granulomatous diseases
    Paolo Spagnolo
    Research Center on Rare Lung Diseases MaRP, Department of Respiratory Diseases, University of Modena and Reggio Emilia, Modena, Italy
    Semin Respir Crit Care Med 29:610-9. 2008
    ..Unraveling how genetic risk factors and environmental triggers interact to determine the disease is challenging but will inevitably have an impact on both diagnostic and therapeutic strategies in granulomatous lung diseases...
  27. ncbi request reprint Room size is the major determinant for tuberculin conversion in health care workers exposed to a multidrug-resistant tuberculosis patient
    Alberto Franchi
    Occupational Health Unit, Policlinico Hospital, 8th Floor, room 8 056, Via Largo del Pozzo 71, 41100 Modena, Italy
    Int Arch Occup Environ Health 80:533-8. 2007
    ..e., index case (IC)]. Aim of the study was to identify the main exposure predictors for the risk of conversion through evaluation of tuberculin screening results...
  28. pmc Bronchopulmonary actinomycosis associated with hiatal hernia
    Alessandro Andreani
    Respiratory Diseases Clinic, Azienda Ospedaliero Universitaria Policlinico, Modena, Italy
    Mayo Clin Proc 84:123-8. 2009
    ..To describe clinicoradiologic and histopathologic features of bronchopulmonary actinomycosis and to determine whether hiatal hernia (HH) is a potential predisposing factor for bronchopulmonary actinomycosis...
  29. pmc Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges
    Paolo Spagnolo
    Center for Rare Lung Disease, University Hospital of Modena, Via del Pozzo 71, 41124, Modena, Italy
    Multidiscip Respir Med 7:42. 2012
    ..However, a multidisciplinary approach to this complex disease is steadily improving diagnostic accuracy, while recent advances in the pharmacological therapy offer the genuine promise of future treatments for this devastating disease...
  30. pmc A culture-proven case of community-acquired legionella pneumonia apparently classified as nosocomial: diagnostic and public health implications
    Annalisa Bargellini
    Department of Clinical, Diagnostic and Public Health Medicine, University of Modena and Reggio Emilia, Via Campi 287, 41125 Modena, Italy
    Case Rep Med 2013:303712. 2013
    ....
  31. ncbi request reprint MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients
    Milena Nasi
    Department of Biomedical Sciences, University of Modena and Reggio Emilia School of Medicine, Via Campi 287, 41100 Modena, Italy
    AIDS 17:1696-8. 2003
    ..The MDR1 C3435Tpolymorphism did not influence response to therapy, suggesting no disadvantages for individuals with a different genotype...